CLINICAL_TRIALS
trial_result
· 2020-07-09
Clinical Trial Update: A Study of BNC210 in Elderly Patients With Agitation [Phase 2]
Summary
Phase 2 trial update for BNC210 in elderly patients with agitation has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bionomics Limited | Conditions: Agitation in the Elderly | Phase 2 | Status: COMPLETED